Axogen price to free cash flow AXGN

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Oct 23, 2026: 238×
Peer median: 28.1×

Axogen's price to free cash flow is 238× as of Oct 23, 2026.

The median for 6 medical device stocks of a similar size is 28.1×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	238×	216×	487×
2025	453×	129×	491×

Against its peers

Companies in Medical - Devices nearest Axogen's size, closest first, today.

Company	Price to free cash flow
AXGNAxogen	238×
TMDXTransMedics	31.0×
CNMDCONMED	11.0×
ITGRInteger	38.4×
LIVNLivaNova	30.1×
ZBHZimmer Biomet	12.3×
ELMDElectromed	26.2×
Peer median	28.1×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Axogen

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.